Australian Inherited Retinal Disease Registry and DNA Bank

About Australian Inherited Retinal Disease Registry & DNA Bank (AIRDR)

Inherited retinal diseases (IRDs) are a group of genetic eye conditions that can cause vision loss and blindness at any age, and are the leading cause of blindness among working-age Australians. With more than 300 genes linked to IRDs, genetic research plays a critical role in improving patient care and developing future treatments.

AIRDR is a national and enduring genetic IRD research program based at Sir Charles Gairdner Hospital in Western Australia, established in 2001. It is Australia’s largest genetic IRD research resource, bringing together genetic, family, and other information from more than 11,000 participants. We have approximately 10,000 DNA samples in our care, representing more than 4,600 Australian families affected by IRD. To date, AIRDR DNA samples have been used for more than 7,200 genetic analyses.

This invaluable program provides an important foundation for national and international research into IRDs, helping us helping us better understand the genetic causes of IRDs, support the development of treatments and personalised medicine, and identify suitable participants for clinical trials and emerging treatments.

 

Supporting research into future treatments

AIRDR collaborates with hospitals, universities, research institutes, and industry partners across Australia and internationally to advance research into IRDs, including retinitis pigmentosa, Stargardt disease, Usher syndrome, cone and rod dystrophies, macular dystrophies, and others. These collaborations support development and access to clinical trials and emerging treatments for Australians affected by IRDs. Under no circumstances will information that can identify individuals or families be shared.

 

Our goals

  • Advance genetic discovery
  • Build a more complete picture of the genetic causes of IRD in Australia
  • Support the development of personalised and other innovative treatments
  • Connect potentially eligible AIRDR participants with clinical trials and treatment programs.

 

Interested in participating or making a donation?

If you have an IRD, or know someone who may be interested in participating, please email scghmtp@health.wa.gov.au with your request. Alternatively, a brochure, including an Expression of Interest form, may be downloaded using the link on this webpage.

To make a donation or to include a bequest in your will, please use the appropriate link on our webpage.

 

AIRDR was established through the generous support of Retina Australia (WA) and Retina Australia, and has received ongoing support from Sir Charles Gairdner Hospital and the Department of Medical Technology and Physics since its inception.

Sir Charles Gairdner Hospital Human Research Ethics Approval: RGS04985.

Last Updated: 11/11/2026